Crossmark

Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

Crossref DOI link: https://doi.org/10.1016/j.arbres.2021.10.002

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Monforte, Víctor

Sintes, Helena

Ussetti, Piedad

Castejón, Raquel

Pérez, Virginia Luz

Laporta, Rosalía

Sole, Amparo

Cifrián, José Manuel

Marcos, Pedro J.

Redel, Javier

Los Arcos, Ibai

Sáez, Berta

Alonso, Rodrigo

Rosado, Silvia

Escriva, Juan

Iturbe, David

Ovalle, Juan Pablo

Vaquero, José Manuel

Revilla, Eva

Mendoza, Alberto

Gómez-Ollés, Susana
Funding

Funding for this research was provided by:

Roche
License Information

Text and Data Mining valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2021.10.002

Content Type: simple-article

Copyright: © 2021 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.